REVIVE (Response to the Ebola Virus Vaccine)

Condition:   Ebola Virus Disease Intervention:   Biological: rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO) Sponsors:   Tulane University;   Kenema Government Hospital;   Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials